Mutual of America Capital Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,580
| Closed | -$27.2K | – | 1488 |
|
|
2023
Q1 | $27.2K | Sell |
2,580
-46
| -2% | -$485 | ﹤0.01% | 1459 |
|
|
2022
Q4 | $89K | Buy |
2,626
+140
| +6% | +$4.75K | ﹤0.01% | 1438 |
|
|
2022
Q3 | $119K | Buy |
2,486
+400
| +19% | +$19.1K | ﹤0.01% | 1493 |
|
|
2022
Q2 | $119K | Buy |
2,086
+313
| +18% | +$17.9K | ﹤0.01% | 1468 |
|
|
2022
Q1 | $143K | Buy |
1,773
+92
| +5% | +$7.42K | ﹤0.01% | 1437 |
|
|
2021
Q4 | $341K | Sell |
1,681
-9,122
| -84% | -$1.85M | ﹤0.01% | 1203 |
|
|
2021
Q3 | $2.91M | Buy |
10,803
+191
| +2% | +$51.5K | 0.03% | 801 |
|
|
2021
Q2 | $2.73M | Sell |
10,612
-253
| -2% | -$65.1K | 0.03% | 846 |
|
|
2021
Q1 | $3.26M | Sell |
10,865
-413
| -4% | -$124K | 0.03% | 742 |
|
|
2020
Q4 | $2.88M | Buy |
11,278
+165
| +1% | +$42.1K | 0.03% | 759 |
|
|
2020
Q3 | $2.77M | Buy |
11,113
+181
| +2% | +$45.1K | 0.04% | 657 |
|
|
2020
Q2 | $3.8M | Buy |
10,932
+21
| +0.2% | +$7.3K | 0.05% | 487 |
|
|
2020
Q1 | $2.92M | Buy |
10,911
+279
| +3% | +$74.7K | 0.05% | 518 |
|
|
2019
Q4 | $3.44M | Buy |
10,632
+9,069
| +580% | +$2.94M | 0.04% | 640 |
|
|
2019
Q3 | $427K | Buy |
1,563
+17
| +1% | +$4.64K | 0.01% | 1127 |
|
|
2019
Q2 | $825K | Sell |
1,546
-7
| -0.5% | -$3.74K | 0.01% | 1096 |
|
|
2019
Q1 | $783K | Buy |
1,553
+8
| +0.5% | +$4.03K | 0.01% | 1098 |
|
|
2018
Q4 | $762K | Buy |
1,545
+65
| +4% | +$32.1K | 0.01% | 1085 |
|
|
2018
Q3 | $1.35M | Buy |
1,480
+97
| +7% | +$88.7K | 0.02% | 1037 |
|
|
2018
Q2 | $1.01M | Sell |
1,383
-5,316
| -79% | -$3.89M | 0.02% | 1093 |
|
|
2018
Q1 | $10.7M | Buy |
6,699
+2,573
| +62% | +$4.1M | 0.17% | 98 |
|
|
2017
Q4 | $3.7M | Buy |
+4,126
| New | +$3.7M | 0.06% | 556 |
|